Literature DB >> 3419188

Membrane permeability parameters for some amino acids and beta-lactam antibiotics: application of the boundary layer approach.

M Hu1, P J Sinko, A L deMeere, D A Johnson, G L Amidon.   

Abstract

The boundary layer approach to analyzing the results of the perfused intestinal segment method of measuring membrane permeabilities is applied to the amino acids; leucine, valine, phenylalanine, lysine and aspartic acid and the beta-lactam antibiotics, cephalexin and penicillin V. The analysis indicates that in determining the membrane parameters, Pw vs. Cw data are preferable to using Jss = PwCw vs. Cw data. It is further shown that the carrier permeability, Pc* = Jmax*/Km, may be the most significant parameter to consider since luminal amino acid or drug concentration may generally be below the Km value. A comparison of P*c values for the beta-lactams with results for passively absorbed compounds indicates that the cephalosporins would be expected to be well absorbed orally based on the perfusion results. This suggests that this approach may be useful in estimating oral drug absorption for compounds that are absorbed passively as well as by a carrier-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3419188     DOI: 10.1016/s0022-5193(88)80124-3

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  19 in total

1.  Analysis of intestinal perfusion data for highly permeable drugs using a numerical aqueous resistance--nonlinear regression method.

Authors:  P J Sinko; G D Leesman; A P Waclawski; H Yu; J H Kou
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

2.  Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption.

Authors:  S Yamashita; Y Tanaka; Y Endoh; Y Taki; T Sakane; T Nadai; H Sezaki
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

3.  Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa.

Authors:  M Hu; P Subramanian; H I Mosberg; G L Amidon
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

4.  Unbiased membrane permeability parameters for gabapentin using boundary layer approach.

Authors:  Jitender Madan; Garima Chawla; Vinod Arora; Rajiv Malik; Arvind K Bansal
Journal:  AAPS J       Date:  2005-09-02       Impact factor: 4.009

5.  Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid.

Authors:  P Langguth; H P Merkle; G L Amidon
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

6.  Methyldopa kinetics before and after ingestion of methyldopa for eight weeks.

Authors:  N R Campbell; A Skerjanec; Y Tam; S Robertson; E Burgess
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Characterization of the oral absorption of beta-lactam antibiotics. I. Cephalosporins: determination of intrinsic membrane absorption parameters in the rat intestine in situ.

Authors:  P J Sinko; G L Amidon
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

8.  Comparison of the transport characteristics of D- and L-methionine in a human intestinal epithelial model (Caco-2) and in a perfused rat intestinal model.

Authors:  L Zheng; J Chen; Y Zhu; H Yang; W Elmquist; M Hu
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

9.  A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.

Authors:  B H Stewart; A R Kugler; P R Thompson; H N Bockbrader
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

10.  Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities.

Authors:  Stephen W J Wang; Kaustubh H Kulkarni; Lan Tang; Jing Rong Wang; Taijun Yin; Tomo Daidoji; Hiroshi Yokota; Ming Hu
Journal:  J Pharmacol Exp Ther       Date:  2009-03-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.